Keith Davidson tells hush-money trial deal to keep Daniels quiet agreed in early October 2017 but payment delayed several ...

During the last 5 trading sessions, EWTX rose by +10.21%, which changed the moving average for the period of 200-days by +124.40% in comparison to the 20-day moving average, which settled at $16.43.

The European Medicines Agency has granted orphan drug designations to one of Edgewise Therapeutics muscular dystrophy drugs.

Regardless of what one thinks of the advisability of a pope known for his off-the-cuff remarks partaking in long interviews, ...

Edgewise Therapeutics (NASDAQ:EWTX) has received orphan drug designation from EU regulators for its drug candidate sevasemten in the treatment of Becker muscular dystrophy and Duchenne muscular ...

As I begin to pen my Ode to Summer, snow is pelting down, gray skies monochroming my world. Summer seems a distant dream.

Does the conversation have a nice back-and-forth, or is it very one-sided? If your date can’t get a word in edgewise, that’s ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Edgewise Therapeutics (EWTX – Research Report) and Progyny (PGNY – Research Report) with bullish ...

Though there are a lot of weapons in Destiny 2, many have been sunset over the years. As we head toward the release of The ...

Sarepta Therapeutics will be releasing earnings Q1 on May 1.Wall Street analysts expect Sarepta Therapeutics will report earnings per share of ...

New York, April 29, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced programming and ...

Keith Davidson tells hush-money trial deal to keep Daniels quiet agreed in early October 2017 but payment delayed several ...